Related Experiment Video
Updated: Jul 13, 2026

03:19
Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes
Published on: June 28, 2024
Carnitine deficiency in pregnancy
Christopher T Donnelly1, Afshan B Hameed, Jose E Abdenur
1Department of Obstetrics and Gynecology, University of California, Irvine, California 92868, USA.
Obstetrics and Gynecology
|August 2, 2007
Summary
Carnitine deficiency can cause metabolic crises. Exogenous carnitine supplementation is effective for treating carnitine deficiency during pregnancy, especially for neonates.
Area of Science:
- Biochemistry
- Genetics
- Metabolic Disorders
Background:
- Carnitine deficiency is a metabolic disorder linked to high energy demand and stress.
- It is characterized by low blood carnitine levels and impaired carnitine transport in fibroblasts.
- Mutations in the OCTN2 gene are commonly associated with this condition.
Observation:
- This case report details the management of a pregnant patient with carnitine deficiency.
- The patient exhibited reduced carnitine transport in fibroblasts but lacked OCTN2 gene mutations.
Findings:
- Carnitine deficiency can be successfully managed with exogenous carnitine during pregnancy.
- This treatment is crucial as carnitine levels naturally decline in pregnant individuals.
Implications:
- Exogenous carnitine is vital for pregnant women with carnitine deficiency and their neonates.
- This highlights the importance of monitoring and managing carnitine levels during pregnancy.
Related Concept Videos
Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Vitamins
Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced in our...
Urea Cycle
The urea cycle describes how liver cells convert ammonia to urea. Ammonia is a toxic waste product of protein catabolism. Land animals must convert ammonia into the less toxic urea which can be safely eliminated by the kidneys through urine. Marine animals excrete ammonia directly, and the surrounding water dilutes the ammonia to safe levels.
Lipid Catabolism
Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
Amino Acid Catabolism
Microorganisms rely on proteins as an essential carbon and energy source, particularly in environments with limited polysaccharides or lipids. However, proteins are too large to cross the plasma membrane unaided, necessitating enzymatic degradation. Microbes secrete extracellular proteases and peptidases that hydrolyze proteins into peptides, which can then be transported across the membrane. Once inside the cell, intracellular proteases degrade these peptides into free amino acids, which...

